. 2010 Oct 11;26(4):683–688. doi: 10.1002/jbmr.274

Table 2.

Annualized Percent Change in BMD of High and Lower Compliance With Placebo and Alendronate

	Placebo		Alendronate

	Lower compliance	High compliance	Lower compliance	High compliance
Total hip	−0.58^a,^b	−0.43^a	−0.30^a	0.99
Femoral neck	−0.30^a,^c	−0.16^a	−0.05^a	1.15
Spine	0.49^a,^c	0.48^a	0.79^a	2.33

Note: Results are adjusted for age, baseline BMD, height, BMI, self-reported health, smoking status, calcium intake, calcium supplement use, having a broken bone after age 45, and having a vertebral fracture at baseline.

p < .0001 compared with alendronate high-compliance group.

^abp = .04 compared with placebo high-compliance group.

^bcp = NS compared with placebo high-compliance group.